Selecta Biosciences Patents – Key Insights and Stats

Selecta Biosciences has a total of 1021 patents globally, out of which 204 have been granted. Of these 1021 patents, more than 55% patents are active. The USA is where Selecta Biosciences has filed the maximum number of patents, followed by Japan and Australia, it has generated an annual revenue of $0.11 billion in the year 2022. Parallelly, the USA seems to be the main focused R&D center of Selecta Biosciences.

Selecta Biosciences was founded in the year 2007. It is a biopharmaceutical company. As of June 2023, Selecta Biosciences has a market cap of $0.20 Billion.

Do read about some of the most popular patents of Selecta Biosciences which have been covered by us in this article and also you can find Selecta Biosciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Selecta Biosciences patent portfolio.

How many patents does Selecta Biosciences have?

Selecta Biosciences has a total of 1021 patents globally. These patents belong to 84 unique patent families. Out of 1021 patents, 568 patents are active.

How Many Patents did Selecta Biosciences File Every Year?

Selecta Biosciences Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantSelecta Biosciences Applications FiledSelecta Biosciences Patents Granted
20224024
20215937
20207428
20195419
20183831
20177821
2016918
20151447
20141143
2013312
2012204
2011110

How many Selecta Biosciences patents are Alive/Dead?

Worldwide Patents

Selecta Biosciences Patent Portfolio

How Many Patents did Selecta Biosciences File in Different Countries?

Selecta Biosciences Worldwide Patent Filing

Countries in which Selecta Biosciences Filed Patents

CountryPatents
United States Of America120
Japan118
Australia110
China107
Israel82
Korea (South)80
Mexico69
Europe64
Canada54
Brazil50
India39
Germany8
Spain8
Denmark7
Hungary5
Hong Kong (S.A.R.)4
Poland3
Italy3
Norway2
Portugal2
Lithuania1
Serbia1
Croatia1
Slovenia1

Where are Research Centres of Selecta Biosciences Patents Located?

R&D Centres of Selecta Biosciences

10 Best Selecta Biosciences Patents

US20120301498A1 is the most popular patent in the Selecta Biosciences portfolio. It has received 440 citations so far from companies like Abbvie, The General Hospital Corporation, and Ethicon.

Below is the list of 10 most cited patents of Selecta Biosciences:

Publication NumberCitation Count
US20120301498A1440
US20110262491A1182
WO2012149259A1162
US20100303850A1146
US20110020388A1141
WO2012149411A1124
US8652487B2121
US20120171229A1117
US20120244222A1104
US20110293701A1104

What are Selecta Biosciences’ key innovation segments?

What Technologies are Covered by Selecta Biosciences?

The chart below distributes patents filed by Selecta Biosciences in different countries on the basis of the technology protected in patents. It also represents the markets where Selecta Biosciences thinks it’s important to protect particular technology inventions.

R&D Focus: How has Selecta Biosciencessearch focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Selecta Biosciences?

Table of Content

Insights you may find interesting

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.